BioStem is dedicated to the relentless pursuit of healing through our commitment to innovation and quality.
Since 2014, BioStem Technologies, Inc. has been a leading biomedical innovator, trusted by clinicians across specialties to deliver best-in-class solutions for advanced Surgical Care and advanced Wound Care. We’re passionate about boldly advancing innovation while upholding the principles of good stewardship that have led to us to where we are today, delivering high quality placental allograft products that inspire confidence in our clinicians and partners and help patients improve their lives.
NEWS & EVENTS:
BIOSTEM IN THE NEWS
Don’t miss an opportunity to catch up with the latest developments in Wound Care and Surgical Care.
BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026
BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference
BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research
BioStem Technologies Advances Entry into the Acute Wound Care Market with Acquisition of BioTissue Holdings’ Surgical and Wound Care Business
BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes
MKTG-047v01